APH insider exercise and sale: 50,000 shares valued $5.5M reported on Form 144
Rhea-AI Filing Summary
Amphenol Corporation (APH) filed a Form 144 reporting a proposed sale of 50,000 common shares through Morgan Stanley Smith Barney, with an aggregate market value of $5,500,820.00. The filing states the company has 1,220,921,111 shares outstanding and lists the approximate date of sale as 08/08/2025. The shares were reported acquired the same day by exercise of options under a registered plan and paid for in cash. The notice also discloses a prior sale of 40,000 shares on 05/29/2025 for gross proceeds of $3,551,408.00. The filer affirms they do not possess undisclosed material adverse information.
Positive
- None.
Negative
- None.
Insights
TL;DR: Small option exercise and planned sale; size is immaterial to float, unlikely to move market price.
The Form 144 shows a proposed sale of 50,000 shares valued at $5,500,820 against an outstanding share base of 1,220,921,111 shares, representing roughly 0.0041% of outstanding shares. The acquisition via exercise of options and immediate intent to sell is a routine liquidity event for insiders or option holders. The previous sale of 40,000 shares on 05/29/2025 for $3,551,408 provides context that this filer has recently monetized restricted holdings. Overall, the disclosure is procedural and consistent with Rule 144 requirements.
TL;DR: Filing documents compliance with Rule 144 and includes the filer’s certification about material information.
The notice records an option exercise and proposed sale routed through a registered broker-dealer, and the signature block includes the standard representation that the filer does not know of undisclosed material adverse information. The form also references trading-plan language, indicating awareness of Rule 10b5-1 considerations. From a governance perspective, the filing demonstrates procedural transparency but does not disclose any governance changes or material corporate events.
FAQ
What did Amphenol (APH) report on Form 144?
Who is handling the proposed sale for APH shares?
When is the approximate date of the proposed sale for APH?
How were the 50,000 shares acquired according to the filing?
Has the filer sold APH shares recently?
Does the filer claim any undisclosed material information in the Form 144?